Overview
Dr. Zoltan Antal is the Director of the Pediatric Diabetes Program in the Division of Pediatric Endocrinology, and an Assistant Professor of Pediatrics at Weill Cornell Medical College. He is also an Assistant Attending Pediatrician at NewYork-Presbyterian Hospital. He is board certified in Pediatrics and Pediatric Endocrinology.
Dr. Antal received a B.S. in Biology from Stony Brook University in Stony Brook, New York and completed his medical degree (M.D.) from St. George’s University School of Medicine in Grenada, West Indies in combination with clinical rotations at Jamaica Hospital in Queens, New York City. He went on to complete his Residency in Pediatrics in Brooklyn, New York at SUNY Downstate Medical Center and Kings County Hospital, where he later served as chief resident. After residency, he remained in New York City and completed a fellowship in Pediatric Endocrinology at the Children’s Hospital at Montefiore in the Bronx.
During his fellowship, Dr. Antal also conducted research at the Albert Einstein College of Medicine in the immunology of diabetes. Specifically, he isolated islet cells from pancreata of diabetic mice and studied the targets of the islet infiltrating T cells. In addition, he was also in charge of the translational component of the research, which entailed examining the peripheral blood of children newly diagnosed with type 1 diabetes, searching for reactivity to the human counterparts of the murine T cell targets.
Finally, Dr. Antal and his colleagues analyzed the HLA supertypes of a subset of diabetic children, publishing the findings in the Annals of the New York Academy of Sciences in 2008.
Highlights
- 1Pediatric blood & cancer · 2023
Publications
Funding
Active
2 grants- Co-IR01DK137517-04Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progressionNational Institute of Diabetes and Digestive and Kidney Diseases · 2023–2028
- PISRA 212039-02T1D Exchange Quality Improvement (QI) InitiativeT1D Exchange · 2020–2026Contract
Clinical research
Completed & closed trials (1)
- PIEnvironmental bisphenols and risk of HypospadiasColumbia University · CLOSED TO ACCRUAL (as of 2024)
News mentions
- Weill Cornell Medicine Community Celebrates Diversity ChampionsApril 28, 2023
In a celebration of Weill Cornell Medicine’s commitment to fostering inclusivity in academic medicine, the institution on April 25 honored nearly a dozen faculty, students and staff who exemplify excellence in diversity, equity and inclusion.
- For Kids’ Sake: WCM-affiliated Program Empowers NYC Nannies to Better Care for Children—and ThemselvesNovember 7, 2019
Empowering NYC nannies to better care for children—and themselves
External relationships
Other
Bayer Healthcare Pharmaceuticals